The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: A British society of blood and marrow transplantation study

British Journal of Haematology

Volumn 134, Issue 4, 2006, Pages 385-390

  Bird, Jennifer M ^a,p   Fuge, Rhian ^a   Sirohi, Bhawna ^b   Apperley, Jane F ^c   Hunter, Ann ^d   Snowden, John ^e   Mahendra, Premini ^f   Milligan, Donald ^g   Byrne, Jenny ^h   Littlewood, Timothy ⁱ   Fegan, Christopher ^j   McQuaker, Grant ^k   Pagliuca, Antonio ^l   Johnson, Peter ^m   Rahemtulla, Amin ^c   Morris, Curly ⁿ   Marks, David I ^o  

^a BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d LEICESTER ROYAL INFIRMARY   (United Kingdom)

^e ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^f QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^g BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^h NOTTINGHAM CITY HOSPITAL   (United Kingdom)

ⁱ JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^j Heath Hospital   (United Kingdom)

^k GLASGOW ROYAL INFIRMARY   (United Kingdom)

^l KING'S COLLEGE LONDON   (United Kingdom)

^m WESTERN GENERAL HOSPITAL   (United Kingdom)

ⁿ BELFAST CITY HOSPITAL   (United Kingdom)

^o BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^p Avon Haematology Unit   (United Kingdom)

more..

Author keywords

Amyloidosis; Dialysis; Melphalan; Myeloma; Renal failure

Indexed keywords

BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; MELPHALAN;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIALYSIS; DRUG MEGADOSE; FEASIBILITY STUDY; FOLLOW UP; GRAFT FAILURE; HUMAN; INFECTION; KIDNEY DISEASE; KIDNEY FUNCTION; MYELOMA; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AMYLOIDOSIS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; HUMANS; KIDNEY DISEASES; MIDDLE AGED; MULTIPLE MYELOMA; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 33746049147     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06191.x     Document Type: Article

References (28)

1. Alexanian, R., Barlogie, B. & Dixon, D. (1990) Renal failure in multiple myeloma. Pathogenesis and prognostic implications. Archives of Internal Medicine, 150, 1693-1695.
2. Attal, M., Harousseau, J.L., Stoppa, A.M., Sotto, J.J., Fuzibet, J.G., Rossi, J.F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C. & Bataille, R. (1996) A prospective randomized trial of autologous transplantation and chemotherapy in multiple myeloma. New England Journal of Medicine, 335, 91-97.
3. Badros, A., Barlogie, B., Siegel, E., Roberts, J., Langmaid, C., Zangari, M., Desikan, R., Shaver, M.J., Fassas, A., McConnell, S., Muwalla, F., Barri, Y., Anaissie, E., Munshi, N. & Tricot, G. (2001) Results of autologous stem cell transplant in multiple myeloma patients with renal failure. British Journal of Haematology, 114, 822-829.
4. Ballester, O.F., Tummala, R., Janssen, W.E., Fields, K.K., Hiemenz, J.W., Goldstein, S.C., Perkins, J.B., Sullivan, D.M., Rosen, R., Sackstein, R., Zorsky, P., Saez, R. & Elfenbein, G.J. (1997) High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency, Bone Marrow Transplantation, 20, 653-656.
5. Barlogie B., Jagannath S., Desikan K.R., Mattox S., Vesole D., Siegel D., Tricot G., Munshi N., Fassas A., Singhal S., Mehta J., Anaissie E., Dhodapkar D., Naucke S., Cromer J., Sawyer J., Epstein J., Spoon D., Ayers D., Cheson B. & Crowley J. (1999) Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood, 93, 55-65.
6. Blade J., Fernandez-Llama P., Bosch F., Montoliu J., Lens X.M., Montoto S., Cases A., Darnell A., Rozman C. & Montserrat E. (1998) Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Archives of Internal Medicine, 158, 1889-1893.
7. Child, J.A., Morgan, G.J., Davies, F.E., Owen, R.G., Bell, S.E., Hawkins, K., Brown, J., Drayson, M.T. & Selby, P.J. (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. New England Journal of Medicine, 348, 1875-1883.
8. Clark, A.D., Shetty, A. & Soutar, R. (1999) Renal failure and multiple myeloma: pathogenesis and treatment of renal failure and management of underlying myeloma. Blood Reviews, 13, 79-90.
9. Comenzo, R. & Gertz, M.A. (2002) Autologous, stem cell transplantation for primary systemic amyloidosis. Blood, 99, 4276-4282.
10. Comenzo, R.L., Vosburgh, E., Falk, R.H., Sanchorawala, V., Reisinger, J., Dubrey, S., Dember, L.M., Berk, J.L., Akpek, G., LaValley, M., O'Hara, C., Arkin, C.F., Wright, D.G. & Skinner, M. (1998) Dose intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: survival and responses in 25 patients. Blood, 91, 3662-3670.
11. Gertz, M.A., Lacy, M.Q., Dispenzieri, A., Gastineau, D.A. & Chen, M.G. (2002) Stem cell transplantation for the management of primary systemic amyloidosis. American Journal of Medicine, 113, 549-555.
12. Gillmore, J.D., Apperley, J.F., Craddock, C., Madhoo, S., Pepys, M.B. & Hawkins, P.N. (1999) High-dose melphalan and stem cell rescue for AL amyloidosis. In: Amyloid and Amyloidosis 1998 (ed. by R.A. Kyle & M.A. Gertz), pp. 102-104. Parthenon Publishing, Pearl River, N.Y.
13. Kergueris, M.F., Milpied, N., Moreau, P., Harousseau, J.L. & Larousse, C. (1994) Pharmacokinetics of high-dose melphalan in adults: influence of renal function. Anticancer Research, 14, 2379-2382.
14. Knudsen, L.M., Nielsen, B., Gimsing, P. & Geisler, C. (2005) Autologous stem cell transplantation in multiple myeloma: outcome in patients with renal failure. European Journal of Haematology, 75, 27-33.
15. Kyle, R.A. (1975) Multiple myeloma: review of 869 cases. Mayo Clinic Proceedings, 50, 29-40.
16. Moreau, P., Leblond, V., Bourquelot, P., Facon, T., Huynh, A., Caillot, D., Hermine, O., Attal, M., Hamidou, M., Nedellec, G., Ferrant, A., Audhuy, B., Bataille, R., Milpied, N. & Harousseau, J.L. (1998) Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients. British Journal of Haematology, 101, 766-769.
17. Rebibou, J.M., Caillot, D., Casasnovas, R.O., Tanter, Y., Maillard, N., Solary, E., Rifle, G. & Guy, H. (1997) Peripheral blood stem cell transplantation in a multiple myeloma patient with end-stage renal failure. Bone Marrow Transplantation, 20, 63-65.
18. Reiter, E., Kalhs, P., Keil, F., Rabitsch, W., Gisslinger, H., Mayer, G., Worel, N., Lechner, K. & Greinix, H.T. (1999) Case report and review of literature. Annals of Haematology, 78, 189-191.
19. Samuels, B.L. & Bitran, J.D. (1995) High-dose intravenous melphalan: a review. Journal of Clinical Oncology, 13, 1786-1799.
20. San Miguel, J.F., Lahuerta, J.J., Garcia-Sanz, R., Alegre, A., Blade, J., Martinez, R., Garcia-Larana, J., De La Rubia, J., Sureda, A., Vidal, M.J., Escudero, A., Perez-Esquiza, E., Conde, E., Garcia-Ruiz, J.C., Cabrera, R., Caballero, D., Moraleda, J.M., Leon, A., Besalduch, J., Hernandez, M.T., Rifon, J., Hernandez, F., Solano, C., Palomera, L., Parody, R., Gonzalez, J.D., Mataix, R., Maldonado, J., Constela, J., Carrera, D., Bello, J.L., De Pablos, J.M., Perez-Simon, J.A., Torres, J.P., Olanguren, J., Prieto, E., Acebede, G., Penarrubia, M.J., Torres, P., Diez-Martin, J.L., Rivas, A., Sanchez, J.M. & Diaz-Mediavilla, J. (2000) Are myeloma patients with renal failure candidates for autologous stem cell transplantation? The Haematology Journal, 1, 28-36.
21. Sanchorawala, V., Wright, D.G., Seldin, D.C., Dember, L.M., Finn, K., Falk, R.H., Berk, J., Quillen, K. & Skinner, M. (2001) An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplantation, 28, 637-642.
22. Schuh, A., Dandridge, J., Haydon, P. & Littlewood, T.J. (1999) Encephalopathy complicating high-dose melphalan. Bone Marrow Transplantation, 24, 1141-1143.
23. Sirohi, B., Powles, R., Mehta, J., Treleaven, J., Raje, N., Kulkarni, S., Rudia, C., Bhagwati, N., Horton, C., Saso, R., Singhal, S. & Parikh, R. (2001) The implication of compromised renal function at presentation in myeloma: similar outcome in patients who receive high-dose therapy: a single-center study of 251 previously untreated patients. Medical Oncology, 18, 39-50.
24. Sirohi, B., Powles, R., Mehta, J., Rudin, C., Kulkarni, S., Horton, C., Saso, R. & Singhal, S. (2005) Treleaven J An elective single autograft with high-dose melphalan: single-center study of 451 patients. Bone Marrow Transplantation, 36, 19-24.
25. Smith, A., Wisloff, F. & Samson, D. (2006) Guidelines on the diagnosis and management of multiple myeloma (2005). British Journal of Haematology, 132, 410-451.
26. Tosi, P., Zamagni, E., Ronconi, S., Benni, M., Motta, M.R., Rizzi, S., Tura, S. & Cavo, M. (2000) Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure. Leukemia, 14, 1310-1313.
27. Tricot, G., Alberts, D.S., Johnson, C., Roe, D.J., Dorr, R.T., Bracy, D., Vesole, D.H., Jagannath, S., Meyers, R. & Barlogie, B. (1996) Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity study. Clinical Cancer Research, 2, 947-952.
28. Winearls, C.G. (1995) Acute myeloma kidney. Kidney International, 48, 1347-1361.